Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (14)

2017

  1. Prevención, diagnóstico y tratamiento de la obesidad. Posicionamiento de la Sociedad Española para el Estudio de la Obesidad de 2016

    Endocrinologia, Diabetes y Nutricion, Vol. 64, pp. 15-22

2016

  1. Cuestionario NutriQol® para la evaluación de la calidad de vida relacionada con la salud (CVRS) en pacientes con nutrición enteral domiciliaria (NED): Validación y primeros resultados

    Nutricion Hospitalaria, Vol. 33, Núm. 6, pp. 1260-1267

  2. Development and validation of a specific questionnaire to assess health-related quality of life in patients with home enteral nutrition: NutriQoL® development

    Patient Preference and Adherence, Vol. 10, pp. 2289-2296

  3. Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease

    Endocrine, Vol. 54, Núm. 3, pp. 681-690

  4. Reliability and Responsiveness of NutriQoL® Questionnaire

    Advances in Therapy, Vol. 33, Núm. 10, pp. 1728-1739

  5. Short-Term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus

    Nutrition and Diabetes, Vol. 6, Núm. 9, pp. e230

2014

  1. Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity

    Endocrine, Vol. 47, Núm. 3, pp. 793-805

2013

  1. Insuficiencia suprarrenal y su tratamiento sustitutivo. Su realidad en España

    Endocrinologia y Nutricion

2012

  1. Dieta proteinada para pacientes con diabetes tipo 2

    Medicina Interna de Mexico, Vol. 28, Núm. 6, pp. 573-578

2010

  1. Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain

    Clinical Endocrinology, Vol. 73, Núm. 1, pp. 35-40

2007

  1. Critical assessment of the current guidelines for the management and treatment of morbidly obese patients

    Journal of Endocrinological Investigation, Vol. 30, Núm. 10, pp. 844-852

  2. Identificación, diagnóstico y control del paciente con obesidad abdominal y factores de riesgo cardiovascular y metabólico

    Medicina Clinica

2006

  1. Efficacy of lanreotide Autogel® administered every 4-8 weeks in patients with acromegaly previously responsive to lanreotide microparticles 30 mg: A phase III trial

    Clinical Endocrinology, Vol. 65, Núm. 3, pp. 320-326

2003

  1. Preoperative lanreotide treatment for GH-secreting pituitary adenomas: Effect on tumour volume and predictive factors of significant tumour shrinkage

    Clinical Endocrinology, Vol. 58, Núm. 4, pp. 471-481